Yıl 2007,
Cilt: 5 Sayı: 1, 18 - 22, 01.06.2007
Öz
Göz vücudun penceresidir ve birçok sistemik hastal›¤›n ilk bulgusu veya sonuçlar› göz muayenesinde karfl›m›za ç›kabilir. Hormonlardaki fizyolojik de¤ifliklikler, baflka nedenle kullan›lan hormon tedavileri ve endokrin hastal›klar gözde baz› de¤iflikliklere neden olur. Bu yaz›da göz ve endokrin sistem aras›ndaki bu etkileflim özetlenecektir.
Anahtar Kelimeler
Kaynakça
- 1. Feldman F, Bain J, Matuk A. Daily assessment of ocular and abnormal variables throughout the menstrual cycle. Arch Ophthalmol 1978; 96:1835-8.
- 2. Fraunfelder FW, Rosenbaum JT. Drug-induced uveitis. Incidence, prevention and treatment. Drug Saf. 1997; 17:197-207.
- 3. Vessey MP, Hannaford P, Mant J, Painter R, Frith P, Chappel D. Oral contraception and eye disease: findings in two large cohort studies. Br J Ophthalmol. 1998; 82:538-42.
- 4. Kroll P, Rodrigues EB, Hoerle S. Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica. 2007; 221:78-94.
- 5. Stemberger K, Kahaly GJ, Pitz S. Update on thyroid eye disease. Compr Ophthalmol Update. 2006; 7:287-98.
- 6. Stawell RJ, Hall AJ. Eye signs in systemic disease. Aust Fam Physician. 2002; 31:217-23.
Yıl 2007,
Cilt: 5 Sayı: 1, 18 - 22, 01.06.2007
Öz
The eye is the window of the body and the initial finding or consequences of a systemic disease may first appear during an eye examination. The physiological changes in the hormones, hormone therapy for various reasons, and endocrine diseases cause some alterations in the eye. The interaction between the eye and the endocrine system will be summarized in this paper.
Anahtar Kelimeler
Kaynakça
- 1. Feldman F, Bain J, Matuk A. Daily assessment of ocular and abnormal variables throughout the menstrual cycle. Arch Ophthalmol 1978; 96:1835-8.
- 2. Fraunfelder FW, Rosenbaum JT. Drug-induced uveitis. Incidence, prevention and treatment. Drug Saf. 1997; 17:197-207.
- 3. Vessey MP, Hannaford P, Mant J, Painter R, Frith P, Chappel D. Oral contraception and eye disease: findings in two large cohort studies. Br J Ophthalmol. 1998; 82:538-42.
- 4. Kroll P, Rodrigues EB, Hoerle S. Pathogenesis and classification of proliferative diabetic vitreoretinopathy. Ophthalmologica. 2007; 221:78-94.
- 5. Stemberger K, Kahaly GJ, Pitz S. Update on thyroid eye disease. Compr Ophthalmol Update. 2006; 7:287-98.
- 6. Stawell RJ, Hall AJ. Eye signs in systemic disease. Aust Fam Physician. 2002; 31:217-23.
Toplam 6 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Bölüm | Collection |
| Yazarlar | |
| Yayımlanma Tarihi | 1 Haziran 2007 |
| Yayımlandığı Sayı | Yıl 2007 Cilt: 5 Sayı: 1 |